Vitality Watch

Dossier pubmed review 30-sep-2026
Narrative review or expert overview without new data

Crosstalk between exosomes and cellular senescence: A core vicious loop promoting α-synuclein pathology in Parkinson’s disease.

Key claim: Exosomes and cellular senescence form a self-reinforcing loop that drives α-synuclein aggregation, neuroinflammation, and mitophagy failure in Parkinson’s disease, and combining engineered exosomes with senolytics is proposed for earlier diagnosis and precision therapy.

Abstract

Parkinson’s disease is characterized by α-synuclein aggregation, dopaminergic neuron loss, and neuroinflammation. Emerging evidence reveals complex crosstalk between exosomes and cellular senescence in Parkinson’s disease pathogenesis. Exosomes mediate α-synuclein transmission and neuroinflammation, while delivering protective factors such as miRNAs that inhibit cellular senescence. Senescent cells secrete pro-inflammatory factors via mitochondrial dysfunction and the senescence-associated secretory phenotype, linking to Parkinson’s disease mitophagy defects. This forms a vicious “senescence-protein deposition-inflammation” cycle, with senescent cell-derived exosomes exacerbating α-synuclein aggregation and inflammation. Therapeutically, exosomes are ideal drug carriers due to blood-brain barrier penetrability and low immunogenicity for targeted antioxidant delivery. Future perspectives highlight exosome-based biomarkers and brain-gut axis intervention as promising directions. We propose integrating exosome engineering and senolytic strategies to lay the foundation for early diagnosis and precision therapy of Parkinson’s disease, promoting diagnosis-intervention translational research and bridging bench-tobedside translation.

Why this matters

Exosomes and cellular senescence form a self-reinforcing loop that drives α-synuclein aggregation, neuroinflammation, and mitophagy failure in Parkinson’s disease, and combining engineered exosomes with senolytics is proposed for earlier diagnosis and precision therapy.

Source

Link

Briefing card

Crosstalk between exosomes and cellular senescence: A core vicious loop promoting α-synuclein pathology in Parkinson's disease.
Stage: review · pubmed · 30-sep-2026

Exosomes and cellular senescence form a self-reinforcing loop that drives α-synuclein aggregation, neuroinflammation, and mitophagy failure in Parkinson’s disease, and combining engineered exosomes with senolytics is proposed for earlier diagnosis and precision therapy.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.4103/NRR.NRRONLINE-D-26-00800

build build 880 · 2bcef25 · 2026-11-18